Multivariable analysis of 63 contemporary patients diagnosed with Nelson's syndrome: A nationwide readmission database study
Abstract
Introduction. Nelson's syndrome (NS) is a rare complication involving enlargement of an adrenocorticotropic hormone (ACTH) producing tumor in the pituitary following bilateral adrenalectomy in Cushing's syndrome. Here, we explore the epidemiology, complication profiles, and readmission statistics of 63 patients diagnosed with NS. Methods. The Nationwide Readmission Database was retrospectively queried for all patients diagnosed with NS (n = 63) or receiving total bilateral adrenalectomy (TBA) surgery (n = 275) between 2016 and 2017. Complications, demographics, and predictive factors were queried for all patients involved. Statistical analysis used Mann-Whitney U nonparametric testing was to compare basic demographics and gaussian-fitted multivariable regression analysis with post hoc odds ratios to compare patient predictors of development of NS and complication rates between the two cohorts. Results. We report the largest contemporary patient series of NS through a nationally-representative inpatient database and explore the clinical characteristics of modern NS patients. Modeling revealed that the absence of primary hypertension served as a significant predictor for NS when compared to the TBA control cohort (OR = 0.88; 95%CI = 0.79–0.99; p = 0.037). In addition, analysis of complications between NS and TBA cohorts revealed that NS patients have significantly higher rates of hypoosmolarity/hyponatremia (OR = 1.42; 95%CI = 1.19–1.71; p = 0.00021), hypopituitarism (OR = 1.94; 95%CI = 1.60–2.36; p < 0.0001), and sepsis (OR = 1.51; 95%CI = 1.14–2.00; p = 0.0046). Conclusion. Contemporary NS is a rare complication of TBA, and modern cases of NS may differ significantly from cases of NS reported in the mid-1900s. As such, a thorough understanding of patient complications and predictive factors for NS are necessary to fully guide patient management in the modern era.
Additional Information
© 2021 Elsevier. Received 5 November 2020, Accepted 25 July 2021, Available online 3 August 2021. There are no conflicts of interest in this study. There are also no disclosures of funding for this study. Institutional Review Board (IRB) approval was not necessary prior to analysis, as the patient cohort was obtained from a publicly available de-identified database. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Additional details
Identifiers
- Eprint ID
- 111342
- DOI
- 10.1016/j.jocn.2021.07.052
- Resolver ID
- CaltechAUTHORS:20211008-224638319
Related works
- Describes
- 10.1016/j.jocn.2021.07.052 (DOI)
Dates
- Created
-
2021-10-11Created from EPrint's datestamp field
- Updated
-
2021-10-11Created from EPrint's last_modified field